Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
Brief
"On December 19, 2024, the Ministry of Health and Welfare (MOHW) held the 12th Advanced Regenerative Medicine and Advanced Biopharmaceutical Deliberation Committee. The committee deliberated on nine clinical research plans, including two high-risk, six medium-risk, and one low-risk studies. Two plans were approved, while seven were rejected."
Highlights content goes here...
Hello!
To view this content, please sign up or log in – it’s free and easy! Stay ahead with curated regulatory insights designed for professionals like you.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
